Personal profile
Expertise related to UN Sustainable Development Goals
In 2015, UN member states agreed to 17 global Sustainable Development Goals (SDGs) to end poverty, protect the planet and ensure prosperity for all. This person’s work contributes towards the following SDG(s):
-
SDG 3 Good Health and Well-being
Fingerprint
The Fingerprint is created by mining the titles and abstracts of the person's research outputs and projects/funding awards to create an index of weighted terms from discipline-specific thesauri.
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
Research output
- 10 Article
-
CSF Hypo-Inflammation Drives Mortality in HIV-Associated Tuberculous Meningitis
Wilt, A. L., Meya, D. B., Cresswell, F. V., Wele, A., Kabahubya, M., Kagimu, E., Gakuru, J., Mugabi, T., Kimuda, S., Namombwe, S., Tukundane, A., Okafor, E., Okurut, S., Scriven, J. E., Dai, B., Engen, N., Bahr, N. C., Boulware, D. R. & Bold, T. D., Apr 15 2026, In: The Journal of infectious diseases. 233, 4, p. 787-798 12 p.Research output: Contribution to journal › Article
Open Access -
Evaluating the Use of Lower Dose Flucytosine for the Treatment of Cryptococcal Meningitis: A Clinical Trial
FLOOR trial team, Jan 15 2026, In: Clinical Infectious Diseases. 82, 1, p. 67-74 8 p.Research output: Contribution to journal › Article › peer-review
Open Access1 Link opens in a new tab Scopus citations -
Headache as a Predictor of Cryptococcal Meningitis in Ambulatory Patients With Symptomatic HIV-associated Cryptococcal Antigenemia
Najjuka, S. M., Poeschla, A., Wele, A., Nalintya, E., Kirumira, P., Ayebale, P., Nakitto, G., Turya, F., Nankungu, L., Skipper, C. P., Fieberg, A., Dai, B., Boulware, D. R., Meya, D. B. & Rajasingham, R., Feb 1 2026, In: Open Forum Infectious Diseases. 13, 2, ofag027.Research output: Contribution to journal › Article › peer-review
Open Access -
Inpatient initiation of tuberculosis preventive therapy with 1 month of isoniazid and rifapentine for adults with advanced HIV disease and cryptococcal meningitis (IMPROVE): a non-inferiority, randomised controlled trial
Ellis, J., Hale, G., Nsangi, L. J., Wele, A., Kigozi, E., Gakuru, J., Kagimu, E., Mugabi, T., Namombwe, S., Kimuda, S., Ssekindi, F., Ndyetukira, J. F., Sadiq, A., Tukundane, A., Bakka, W., Harrison, T. S., Mande, E., Muzoora, C., Moore, D. A. J. & Meya, D. B. & 3 others, , Mar 2026, In: The Lancet HIV. 13, 3, p. e153-e162Research output: Contribution to journal › Article › peer-review
Open Access1 Link opens in a new tab Scopus citations -
Adjunctive Single-Dose Liposomal Amphotericin to Prevent Cryptococcal Meningitis in People With HIV–Associated Cryptococcal Antigenemia and Low Plasma Cryptococcal Antigen Titers
Meya, D. B., Nalintya, E., Skipper, C. P., Kirumira, P., Ayebare, P., Naluyima, R., Namuli, T., Turya, F., Walukaga, S., Engen, N. S., Huppler Hullsiek, K., Wele, A., Dai, B., Boulware, D. R. & Rajasingham, R., Jan 15 2025, In: Clinical Infectious Diseases. 80, 1, p. 129-136 8 p.Research output: Contribution to journal › Article › peer-review
Open Access7 Link opens in a new tab Scopus citations